IKT   $1.725  -1.99% Market Open

Inhibikase Therapeutics, Inc.
Total Cash 7.94M
totalCashPerShare 1.064
EBITDA -18.98M
Total Debt 355.09K
quickRatio 2.143
currentRatio 2.322
Total Revenue 79.57K
debtToEquity 6.967
Revenue/Share 0.014
ROA -0.76206
ROE -1.4968699
grossProfits
freeCashflow -10.34M
operatingCashflow -16.47M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -238.85052
profitMargins 0.0
enterpriseValue 12.19M
forwardPE -10.76
floatShares 1.70M
sharesOutstanding 65.77M
sharesShort 227.28K
sharesShortPriorMonth 39.66K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.10%
heldPercentInstitutions 0.12%
Short Ratio help_outline 0.23%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 0.706
Price To Book help_outline 3.81
earningsQuarterlyGrowth
netIncomeToCommon -18.38M
trailingEps -3.21%
forwardEps -0.25%
enterpriseToEbitda -0.64
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.37 3Q 2024
institutionsCount 15
lastUpdated Nov. 7, 2024, 3:28 a.m.